Anthera Pharmaceuticals Inc


Anthera Pharmaceuticals Inc (ANTH) Runs Downhill Following Disappointing Phase 3 Clinical Data

Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes medical gold. A lottery ticket, however, costs only …

Company Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Announces Encouraging Top-Line Phase 3 Trial Results in Cystic Fibrosis Patients with Exocrine Pancreatic Insufficiency

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced the top line results of the SOLUTION clinical study in cystic fibrosis patients with exocrine pancreatic insufficiency (EPI). …

Stock Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Announces Continuation of SIMPLICITY Study of Sollpura Following Positive DMC Review

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced that the Data Monitoring Committee (DMC) completed its pre-planned safety review of the SIMPLICITY clinical study of Sollpura …

Company Update (NASDAQ:ANTH): Here’s Why Anthera Pharmaceuticals Inc Are Falling 23% Today

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) are having a rough day after the drug maker announced that the CHABLIS-SC1 clinical trial with blisibimod for the treatment …

Company Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Announces Positive DSMB Review in Phase 3 SOLUTION Study of Sollpura

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) announced that the Data and Safety Monitoring Board (DSMB) completed its first pre-planned safety review of the Phase 3 SOLUTION …

Company Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Provides Clinical Program Updates for Blisibimod and Sollpura

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced results from interim analysis of the Phase 2 BRIGHT-SC proof-of-concept study in 57 patients with biopsy-proven IgA Nephropathy. Additionally, …

Stock Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Provides Business Update and Reports 2016 First Quarter Financial Results

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) provided a business update and reported financial results for the first quarter ended March 31, 2016. Recent Developments and Business Highlights: …

Stock Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Provides Business Update and Reports Third Quarter 2015 Financial Results

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) provided a business update and reported financial results for the third quarter ended September 30, 2015. Recent Developments and Business Highlights: …

Stock Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Announces Termination of Blisibimod Partnership in Japan by Zenyaku

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced receipt of a termination notice from its development partner in Japan, Zenyaku, terminating the December 2014 Collaboration and License …

Stock Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Reports 2Q:15 and Operational Update

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced financial results and an operational update for the second quarter ended June 30, 2015. Net loss for the quarter …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts